GDF15 and pulmonary arterial hypertension: The clinical study is cross sectional, was conducted in a single, heterogeneous population, the ROC curve is unvalidated and the animal model studies are associative, which can only suggest, but not prove, a causal link between GDF-15 and muscle loss in PAH.